A citation-based method for searching scientific literature

Davide Angeli, Samanta Salvi, Gianluca Tedaldi. Int J Mol Sci 2020
Times Cited: 13







List of co-cited articles
60 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Gene-panel sequencing and the prediction of breast-cancer risk.
Douglas F Easton, Paul D P Pharoah, Antonis C Antoniou, Marc Tischkowitz, Sean V Tavtigian, Katherine L Nathanson, Peter Devilee, Alfons Meindl, Fergus J Couch, Melissa Southey,[...]. N Engl J Med 2015
488
38

Contribution of MUTYH Variants to Male Breast Cancer Risk: Results From a Multicenter Study in Italy.
Piera Rizzolo, Valentina Silvestri, Agostino Bucalo, Veronica Zelli, Virginia Valentini, Irene Catucci, Ines Zanna, Giovanna Masala, Simonetta Bianchi, Alessandro Mauro Spinelli,[...]. Front Oncol 2018
14
23

Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel.
Nadine Tung, Chiara Battelli, Brian Allen, Rajesh Kaldate, Satish Bhatnagar, Karla Bowles, Kirsten Timms, Judy E Garber, Christina Herold, Leif Ellisen,[...]. Cancer 2015
252
23

Insight into genetic susceptibility to male breast cancer by multigene panel testing: Results from a multicenter study in Italy.
Piera Rizzolo, Veronica Zelli, Valentina Silvestri, Virginia Valentini, Ines Zanna, Simonetta Bianchi, Giovanna Masala, Alessandro Mauro Spinelli, Maria Grazia Tibiletti, Antonio Russo,[...]. Int J Cancer 2019
20
23

Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations.
Hanne Meijers-Heijboer, Ans van den Ouweland, Jan Klijn, Marijke Wasielewski, Anja de Snoo, Rogier Oldenburg, Antoinette Hollestelle, Mark Houben, Ellen Crepin, Monique van Veghel-Plandsoen,[...]. Nat Genet 2002
767
23

The risk of gastric cancer in carriers of CHEK2 mutations.
Urszula Teodorczyk, Cezary Cybulski, Dominika Wokołorczyk, Anna Jakubowska, Teresa Starzyńska, Małgorzata Lawniczak, Paweł Domagała, Katarzyna Ferenc, Krzysztof Marlicz, Zbigniew Banaszkiewicz,[...]. Fam Cancer 2013
31
23

Multiple-gene panel analysis in a case series of 255 women with hereditary breast and ovarian cancer.
Gianluca Tedaldi, Michela Tebaldi, Valentina Zampiga, Rita Danesi, Valentina Arcangeli, Mila Ravegnani, Ilaria Cangini, Francesca Pirini, Elisabetta Petracci, Andrea Rocca,[...]. Oncotarget 2017
42
23

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
Sue Richards, Nazneen Aziz, Sherri Bale, David Bick, Soma Das, Julie Gastier-Foster, Wayne W Grody, Madhuri Hegde, Elaine Lyon, Elaine Spector,[...]. Genet Med 2015
23

A possible role of FANCM mutations in male breast cancer susceptibility: Results from a multicenter study in Italy.
Valentina Silvestri, Piera Rizzolo, Veronica Zelli, Virginia Valentini, Ines Zanna, Simonetta Bianchi, Maria Grazia Tibiletti, Liliana Varesco, Antonio Russo, Stefania Tommasi,[...]. Breast 2018
11
18

CHEK2*1100delC genotyping for clinical assessment of breast cancer risk: meta-analyses of 26,000 patient cases and 27,000 controls.
Maren Weischer, Stig Egil Bojesen, Christina Ellervik, Anne Tybjaerg-Hansen, Børge Grønne Nordestgaard. J Clin Oncol 2008
182
15

Male breast cancer: genetics, epigenetics, and ethical aspects.
P Rizzolo, V Silvestri, S Tommasi, R Pinto, K Danza, M Falchetti, M Gulino, P Frati, L Ottini. Ann Oncol 2013
52
15

CHEK2*1100delC homozygosity is associated with a high breast cancer risk in women.
Muriel A Adank, Marianne A Jonker, Irma Kluijt, Saskia E van Mil, Rogier A Oldenburg, Wolter J Mooi, Frans B L Hogervorst, Ans M W van den Ouweland, Johan J P Gille, Marjanka K Schmidt,[...]. J Med Genet 2011
41
15

PALB2 mutations in male breast cancer: a population-based study in Central Italy.
Valentina Silvestri, Piera Rizzolo, Ines Zanna, Mario Falchetti, Giovanna Masala, Simonetta Bianchi, Laura Papi, Giuseppe Giannini, Domenico Palli, Laura Ottini. Breast Cancer Res Treat 2010
32
15

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
15

Gene panel sequencing in familial breast/ovarian cancer patients identifies multiple novel mutations also in genes others than BRCA1/2.
Cornelia Kraus, Juliane Hoyer, Georgia Vasileiou, Marius Wunderle, Michael P Lux, Peter A Fasching, Mandy Krumbiegel, Steffen Uebe, Miriam Reuter, Matthias W Beckmann,[...]. Int J Cancer 2017
59
15

Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2.
Valentina Silvestri, Daniel Barrowdale, Anna Marie Mulligan, Susan L Neuhausen, Stephen Fox, Beth Y Karlan, Gillian Mitchell, Paul James, Darcy L Thull, Kristin K Zorn,[...]. Breast Cancer Res 2016
33
15


RAD51C germline mutations in breast and ovarian cancer patients.
Mohammad R Akbari, Patricia Tonin, William D Foulkes, Parviz Ghadirian, Marc Tischkowitz, Steven A Narod. Breast Cancer Res 2010
38
15

Male breast cancer in Cowden syndrome patients with germline PTEN mutations.
J D Fackenthal, D J Marsh, A L Richardson, S A Cummings, C Eng, B G Robinson, O I Olopade. J Med Genet 2001
102
15

Germline deleterious mutations in genes other than BRCA2 are infrequent in male breast cancer.
Florentia Fostira, Emmanouil Saloustros, Paraskevi Apostolou, Andromahi Vagena, Despoina Kalfakakou, Davide Mauri, Dimitrios Tryfonopoulos, Vassileios Georgoulias, Drakoulis Yannoukakos, Georgios Fountzilas,[...]. Breast Cancer Res Treat 2018
16
15


CHEK2 contribution to hereditary breast cancer in non-BRCA families.
Alexis Desrichard, Yannick Bidet, Nancy Uhrhammer, Yves-Jean Bignon. Breast Cancer Res 2011
48
15

Whole-exome sequencing and targeted gene sequencing provide insights into the role of PALB2 as a male breast cancer susceptibility gene.
Valentina Silvestri, Veronica Zelli, Virginia Valentini, Piera Rizzolo, Anna Sara Navazio, Anna Coppa, Simona Agata, Cristina Oliani, Daniela Barana, Tiziana Castrignanò,[...]. Cancer 2017
18
15

Prevalence of BRCA1 and BRCA2 mutations in male breast cancer patients in Canada.
N Wolpert, E Warner, M F Seminsky, A Futreal, S A Narod. Clin Breast Cancer 2000
17
15

Male breast cancer in a multi-gene panel testing cohort: insights and unexpected results.
Mary Pritzlaff, Pia Summerour, Rachel McFarland, Shuwei Li, Patrick Reineke, Jill S Dolinsky, David E Goldgar, Hermela Shimelis, Fergus J Couch, Elizabeth C Chao,[...]. Breast Cancer Res Treat 2017
58
15

Mutations in BRCA2 and PALB2 in male breast cancer cases from the United States.
Yuan Chun Ding, Linda Steele, Chih-Jen Kuan, Scott Greilac, Susan L Neuhausen. Breast Cancer Res Treat 2011
72
15

Breast cancer risk among male BRCA1 and BRCA2 mutation carriers.
Yu Chuan Tai, Susan Domchek, Giovanni Parmigiani, Sining Chen. J Natl Cancer Inst 2007
181
15

CHEK2 is a multiorgan cancer susceptibility gene.
C Cybulski, B Górski, T Huzarski, B Masojć, M Mierzejewski, T Debniak, U Teodorczyk, T Byrski, J Gronwald, J Matyjasik,[...]. Am J Hum Genet 2004
310
15

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
15

Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutations.
A Moran, C O'Hara, S Khan, L Shack, E Woodward, E R Maher, F Lalloo, D G R Evans. Fam Cancer 2012
159
15

Risk of breast cancer in women with a CHEK2 mutation with and without a family history of breast cancer.
Cezary Cybulski, Dominika Wokołorczyk, Anna Jakubowska, Tomasz Huzarski, Tomasz Byrski, Jacek Gronwald, Bartłomiej Masojć, Tadeusz Deebniak, Bohdan Górski, Paweł Blecharz,[...]. J Clin Oncol 2011
125
15

Evaluation of CYP17A1 and CYP1B1 polymorphisms in male breast cancer risk.
Piera Rizzolo, Valentina Silvestri, Virginia Valentini, Veronica Zelli, Agostino Bucalo, Ines Zanna, Simonetta Bianchi, Maria Grazia Tibiletti, Antonio Russo, Liliana Varesco,[...]. Endocr Connect 2019
2
100

Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families.
Xin Yang, Goska Leslie, Alicja Doroszuk, Sandra Schneider, Jamie Allen, Brennan Decker, Alison M Dunning, James Redman, James Scarth, Inga Plaskocinska,[...]. J Clin Oncol 2020
77
15

Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene.
Alfons Meindl, Heide Hellebrand, Constanze Wiek, Verena Erven, Barbara Wappenschmidt, Dieter Niederacher, Marcel Freund, Peter Lichtner, Linda Hartmann, Heiner Schaal,[...]. Nat Genet 2010
451
15

ATM-Deficient Cancers Provide New Opportunities for Precision Oncology.
Nicholas R Jette, Mehul Kumar, Suraj Radhamani, Greydon Arthur, Siddhartha Goutam, Steven Yip, Michael Kolinsky, Gareth J Williams, Pinaki Bose, Susan P Lees-Miller. Cancers (Basel) 2020
30
15

Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing.
Lisa R Susswein, Megan L Marshall, Rachel Nusbaum, Kristen J Vogel Postula, Scott M Weissman, Lauren Yackowski, Erica M Vaccari, Jeffrey Bissonnette, Jessica K Booker, M Laura Cremona,[...]. Genet Med 2016
152
15

Clinical implications of germline mutations in breast cancer: TP53.
Katherine Schon, Marc Tischkowitz. Breast Cancer Res Treat 2018
39
15

Genetic Testing and Clinical Management Practices for Variants in Non-BRCA1/2 Breast (and Breast/Ovarian) Cancer Susceptibility Genes: An International Survey by the Evidence-Based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) Clinical Working Group.
Sarah M Nielsen, Diana M Eccles, Iris L Romero, Fahd Al-Mulla, Judith Balmaña, Michela Biancolella, Rien Bslok, Maria Adelaide Caligo, Mariarosaria Calvello, Gabriele Lorenzo Capone,[...]. JCO Precis Oncol 2018
12
16

CHEK2 (∗) 1100delC Mutation and Risk of Prostate Cancer.
Victoria Hale, Maren Weischer, Jong Y Park. Prostate Cancer 2014
32
15

Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer.
Fergus J Couch, Steven N Hart, Priyanka Sharma, Amanda Ewart Toland, Xianshu Wang, Penelope Miron, Janet E Olson, Andrew K Godwin, V Shane Pankratz, Curtis Olswold,[...]. J Clin Oncol 2015
355
15


CHEK2 mutations and the risk of papillary thyroid cancer.
Monika Siołek, Cezary Cybulski, Danuta Gąsior-Perczak, Artur Kowalik, Beata Kozak-Klonowska, Aldona Kowalska, Małgorzata Chłopek, Wojciech Kluźniak, Dominika Wokołorczyk, Iwona Pałyga,[...]. Int J Cancer 2015
60
15

Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer.
Fergus J Couch, Hermela Shimelis, Chunling Hu, Steven N Hart, Eric C Polley, Jie Na, Emily Hallberg, Raymond Moore, Abigail Thomas, Jenna Lilyquist,[...]. JAMA Oncol 2017
269
15

BRCA genes: BRCA 1 and BRCA 2.
Umut Varol, Yuksel Kucukzeybek, Ahmet Alacacioglu, Isil Somali, Zekiye Altun, Safiye Aktas, Mustafa Oktay Tarhan. J BUON 2018
9
22


Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes.
Nasim Mavaddat, Kyriaki Michailidou, Joe Dennis, Michael Lush, Laura Fachal, Andrew Lee, Jonathan P Tyrer, Ting-Huei Chen, Qin Wang, Manjeet K Bolla,[...]. Am J Hum Genet 2019
231
15

Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores.
Julie Lecarpentier, Valentina Silvestri, Karoline B Kuchenbaecker, Daniel Barrowdale, Joe Dennis, Lesley McGuffog, Penny Soucy, Goska Leslie, Piera Rizzolo, Anna Sara Navazio,[...]. J Clin Oncol 2017
70
15

Beyond BRCA: new hereditary breast cancer susceptibility genes.
P Economopoulou, G Dimitriadis, A Psyrri. Cancer Treat Rev 2015
90
15


Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer.
Talia Golan, Pascal Hammel, Michele Reni, Eric Van Cutsem, Teresa Macarulla, Michael J Hall, Joon-Oh Park, Daniel Hochhauser, Dirk Arnold, Do-Youn Oh,[...]. N Engl J Med 2019
487
15


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.